Patients in the low-dose cohort who have completed 36 weeks of treatment,9 out of 11 (81.8%) achieved overall clinical remission and 10 out of 11 (91%) achieved immunological complete remission.
PRINCETON,N.J.,SHANGHAI and SUZHOU,China,Dec. 4,2024-- Duality Biologics ("DualityBio"),a clinical-stage biotech company focusing on the discovery and development of next-generation antibod
SYDNEY,Dec. 1,2024--Booking.com\'s annual Travel Predictions research* reveals how Australian travellers are \'rewriting the playbook\' in 2025 by defying the rules of conventional getaways and as a r
HANGZHOU,China,Dec. 1,2024-- ZEEKR Intelligent Technology Holding Limited ("ZEEKR" or the "Company") (NYSE: ZK),a global premium electric mobility technology company,today announce
NEW YORK,Nov. 30,2024-- After an exciting Black Friday event filled with exclusive discounts and unbeatable offers on Monport Laser\'s cutting-edge machines,the excitement isn\'t over just yet. Monpor
